<code id='CD88CAC47B'></code><style id='CD88CAC47B'></style>
    • <acronym id='CD88CAC47B'></acronym>
      <center id='CD88CAC47B'><center id='CD88CAC47B'><tfoot id='CD88CAC47B'></tfoot></center><abbr id='CD88CAC47B'><dir id='CD88CAC47B'><tfoot id='CD88CAC47B'></tfoot><noframes id='CD88CAC47B'>

    • <optgroup id='CD88CAC47B'><strike id='CD88CAC47B'><sup id='CD88CAC47B'></sup></strike><code id='CD88CAC47B'></code></optgroup>
        1. <b id='CD88CAC47B'><label id='CD88CAC47B'><select id='CD88CAC47B'><dt id='CD88CAC47B'><span id='CD88CAC47B'></span></dt></select></label></b><u id='CD88CAC47B'></u>
          <i id='CD88CAC47B'><strike id='CD88CAC47B'><tt id='CD88CAC47B'><pre id='CD88CAC47B'></pre></tt></strike></i>

          Home / explore / fashion

          fashion


          fashion

          author:Wikipedia    Page View:39
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In